✦ LIBER ✦

Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugs

✍ Scribed by Susan M. Chang; John Kuhn; Patrick Wen; Harry Greenberg; David Schiff; Charles Conrad; Karen Fink; H. Ian Robins; Timothy Cloughesy; Lisa De Angelis; Jeffrey Razier; Kenneth Hess; Janet Dancey; Michael D. Prados

Book ID: 111579924
Publisher: Springer US
Year: 2004
Tongue: English
Weight: 115 KB
Volume: 22
Category: Article
ISSN: 0167-6997
DOI: 10.1023/b:drug.0000036685.72140.03

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I, bioavailability, and pharmacoki

Phase I, bioavailability, and pharmacokinetic study of oral dosage of CCI-779 administered to patients with advanced solid malignancies

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 145 KB

A phase I/II trial and pharmacokinetic s

A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas

✍ David M. Peereboom; Jeffrey G. Supko; Kathryn A. Carson; Tracy Batchelor; Surasa 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 187 KB

Erratum to: A phase I/II trial and pharm

Erratum to: A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas

✍ David M. Peereboom; Jeffrey G. Supko; Kathryn A. Carson; Tracy Batchelor; Surasa 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 86 KB

Phase I trial with biomarker studies of

Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomide

✍ Elizabeth R. Gerstner; April F. Eichler; Scott R. Plotkin; Jan Drappatz; Colin L 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 244 KB

Phase I pharmacokinetic and pharmacodyna

Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies

✍ D. Mahadevan; E.G. Chiorean; W.B. Harris; D.D. Von Hoff; A. Stejskal-Barnett; W. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 791 KB

Population pharmacokinetic/pharmacodynam

Population pharmacokinetic/pharmacodynamic modeling of drug-induced adverse effects of a novel homocamptothecin analog, elomotecan (BN80927), in a Phase I dose finding study in patients with advanced solid tumors

✍ Iñaki F. Trocóniz, Josep-María Cendrós, Elena Soto… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 510 KB